Higher Fecal Short-Chain Fatty Acid Levels Are Associated with Gut Microbiome Dysbiosis, Obesity, Hypertension and Cardiometabolic Disease Risk Factors
Open accessThe DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Abstract
Fiber fermentation by gut microbiota yields short-chain fatty acids (SCFAs) that are either absorbed by the gut or excreted in feces. Studies are conflicting as to whether SCFAs are beneficial or detrimental to cardiometabolic health, and how gut microbiota associated with SCFAs is unclear. In this study of 441 community-dwelling adults, we examined associations of fecal SCFAs, gut microbiota diversity and composition, gut permeability, and cardiometabolic outcomes, including obesity and hypertension. We assessed fecal microbiota by 16S rRNA gene sequencing, and SCFA concentrations by gas chromatography/mass spectrometry. Fecal SCFA concentrations were inversely associated with microbiota diversity, and 70 unique microbial taxa were differentially associated with at least one SCFA (acetate, butyrate or propionate). Higher SCFA concentrations were associated with a measure of gut permeability, markers of metabolic dysregulation, obesity and hypertension. Microbial diversity showed association with these outcomes in the opposite direction. Associations were significant after adjusting for measured confounders. In conclusion, higher SCFA excretion was associated with evidence of gut dysbiosis, gut permeability, excess adiposity, and cardiometabolic risk factors. Studies assessing both fecal and circulating SCFAs are needed to test the hypothesis that the association of higher fecal SCFAs with obesity and cardiometabolic dysregulation is due to less efficient SCFA absorption.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Million, M., Angelakis, E., Maraninchi, M., Henry, M., Giorgi, R., Valero, R., Vialettes, B., & Raoult, D. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.20 · Cited by 362
RetractedSchloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549 · cited 1×
“36 [22] following its standard operating procedure available November 2015.”
MethodAn obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 1×
“, homozygous for a mutation in the leptin gene (ob/ob) that produces a stereotyped, fully penetrant obesity phenotype) compared to their lean siblings (ob/+ and +/+) have a gut microbiome composition that promotes obesity through excess SCFA production and increased energy availability [14].”
BackgroundStructure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB
DeSantis, T. Z., Hugenholtz, P., Larsen, N., Rojas, M., Brodie, E. L., Keller, K., Huber, T., Dalevi, D., Hu, P., & Andersen, G. L. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.03006-05 · Cited by 10,891 · cited 1×
“OTUs delimited at 97% identity were generated and classified using Greengenes 13_8_99 [23].”
MethodA core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823 · cited 1×
“, acetyl/propionyl-CoA carboxylase and acetyl-CoA carboxylase) [17].”
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638 · cited 1×
“LBP is a biomarker of bacterial-derived LPS translocation from the gut to the periphery and higher serum LBP levels are thought to reflect gut permeability [43] and metabolic endotoxemia [44].”
BackgroundThe Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413 · cited 1×
“SCFAs may also be involved in appetite regulation [9], and play a role in gut and peripheral immune responses [10]; inducing the differentiation of T-regulatory cells [11].”
BackgroundCani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219451110 · Cited by 4,511 · cited 1×
“On the other hand, participants with lower fecal SCFA excretion had a diverse microbiome, enriched in beneficial microbes including Akkermansia muciniphila, a taxon involved in maintaining the integrity of the mucin layer [50]; Christensenellaceae, Methanobrevibacter and Oscillospira, taxa associated with lower BMI [5…”
Background
Research works printed but not linked: 1
- (2017, June 01). IPAQ Research Committee Guidelines for Data Processing and Analysis of the International Physical Activity Questionnaire (IPAQ): Short and Long Forms. Available online: http://www.academia.edu/5346814/Guidelines_for_Data_Processing_and_Analysis_of_the_International_Physical_Activity_Questionnaire_IPAQ_Short_and_Long_Forms_Contents.
Cited by
Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes
Scheithauer, T. P. M., Rampanelli, E., Nieuwdorp, M., Vallance, B. A., Verchere, C. B., van Raalte, D. H., & Herrema, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.571731 · Cited by 673
“Surprisingly in obesity, an increased SCFA production has been observed (158, 159), which was proposed to be responsible for higher energy extraction (160) and was dependent on the diet (161).”
BackgroundLiu, B.-N., Liu, X.-T., Liang, Z.-H., & Wang, J.-H. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i25.3837 · Cited by 606
Meslier, V., Laiola, M., Roager, H. M., De Filippis, F., Roume, H., Quinquis, B., Giacco, R., Mennella, I., Ferracane, R., Pons, N., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-320438 · Cited by 583
Facchin, S., Bertin, L., Bonazzi, E., Lorenzon, G., De Barba, C., Barberio, B., Zingone, F., Maniero, D., Scarpa, M., Ruffolo, C., et al. (2024) · Life · doi:10.3390/life14050559 · Cited by 380
“Indeed, a previous survey of 441 adults published by Cuesta-Zuluaga et al., in 2018 revealed a correlation between higher fecal SCFAs levels and obesity [281].”
ResultAho, V. T. E., Houser, M. C., Pereira, P. A. B., Chang, J., Rudi, K., Paulin, L., Hertzberg, V., Auvinen, P., Tansey, M. G., & Scheperjans, F. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00427-6 · Cited by 435
Gut Microbiota in Hypertension and Atherosclerosis: A Review
Verhaar, B. J. H., Prodan, A., Nieuwdorp, M., & Muller, M. (2020) · Nutrients · doi:10.3390/nu12102982 · Cited by 400
“2019 441 subjects No hypertension groups 16S NR NR Lower Unadjusted [30]”
BackgroundMüller, M., Hernández, M. A. G., Goossens, G. H., Reijnders, D., Holst, J. J., Jocken, J. W. E., van Eijk, H., Canfora, E. E., & Blaak, E. E. (2019) · Scientific Reports · doi:10.1038/s41598-019-48775-0 · Cited by 324
Kim, K. N., Yao, Y., & Ju, S. Y. (2019) · Nutrients · doi:10.3390/nu11102512 · Cited by 327
Biomarkers of Nutrition and Health: New Tools for New Approaches
Picó, C., Serra, F., Rodríguez, A. M., Keijer, J., & Palou, A. (2019) · Nutrients · doi:10.3390/nu11051092 · Cited by 287
The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
Wang, Q., Luo, Y., Ray Chaudhuri, K., Reynolds, R., Tan, E.-K., & Pettersson, S. (2021) · Brain · doi:10.1093/brain/awab156 · Cited by 281
Characteristics of gut microbiota in people with obesity
Duan, M., Wang, Y., Zhang, Q., Zou, R., Guo, M., & Zheng, H. (2021) · PLOS ONE · doi:10.1371/journal.pone.0255446 · Cited by 225
Gut metagenomic and short chain fatty acids signature in hypertension: a cross-sectional study
Calderón-Pérez, L., Gosalbes, M. J., Yuste, S., Valls, R. M., Pedret, A., Llauradó, E., Jimenez-Hernandez, N., Artacho, A., Pla-Pagà, L., Companys, J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-63475-w · Cited by 224
“In a recent study de la Cuesta-Zuluaga et al. (2018)15 reported in a human cohort that higher fecal SCFA concentrations were associated with a measure of gut permeability and also hypertension.”
BackgroundResultHoutman, T. A., Eckermann, H. A., Smidt, H., & de Weerth, C. (2022) · Scientific Reports · doi:10.1038/s41598-022-07176-6 · Cited by 213
Verhaar, B. J. H., Collard, D., Prodan, A., Levels, J. H. M., Zwinderman, A. H., Bäckhed, F., Vogt, L., Peters, M. J. L., Muller, M., Nieuwdorp, M., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa704 · Cited by 219
“Faecal SCFA levels were higher in subjects with higher BP, which is in line with previous results from other cohort studies that examined the relation between faecal SCFAs and BP.(8,9) These positive associations between BP and faecal SCFA levels in our cohort seem to conflict with the negative associations found betw…”
ResultThe Gut Microbiome in Hypertension: Recent Advances and Future Perspectives
Avery, E. G., Bartolomaeus, H., Maifeld, A., Marko, L., Wiig, H., Wilck, N., Rosshart, S. P., Forslund, S. K., & Müller, D. N. (2021) · Circulation Research · doi:10.1161/circresaha.121.318065 · Cited by 168
Short-chain fatty acid: An updated review on signaling, metabolism, and therapeutic effects
Rekha, K., Venkidasamy, B., Samynathan, R., Nagella, P., Rebezov, M., Khayrullin, M., Ponomarev, E., Bouyahya, A., Sarkar, T., Shariati, M. A., et al. (2024) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2124231 · Cited by 162
“Further, the study revealed that extensive investigation on the relationship between elevated fecal SCFAs and obesity and cardiovascular risk dysregulation is still necessary because of inefficient SCFA absorption (de la Cuesta-Zuluaga et al. 2018).”
BackgroundOliver, A., Chase, A. B., Weihe, C., Orchanian, S. B., Riedel, S. F., Hendrickson, C. L., Lay, M., Sewall, J. M., Martiny, J. B. H., & Whiteson, K. (2021) · mSystems · doi:10.1128/msystems.00115-21 · Cited by 171
Lange, O., Proczko-Stepaniak, M., & Mika, A. (2023) · Current Obesity Reports · doi:10.1007/s13679-023-00503-6 · Cited by 179
The gut microbiome and cardiovascular disease: current knowledge and clinical potential
Ahmad, A. F., Dwivedi, G., O’Gara, F., Caparros-Martin, J. A., & Ward, N. C. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00376.2019 · Cited by 172
Overby, H., & Ferguson, J. F. (2021) · Current Hypertension Reports · doi:10.1007/s11906-020-01125-2 · Cited by 170
Benefits of bacteria-derived exopolysaccharides on gastrointestinal microbiota, immunity and health
Oerlemans, M. M. P., Akkerman, R., Ferrari, M. D. L., Walvoort, M. T. C., & de Vos, P. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104289 · Cited by 167
Differential Analysis of Hypertension-Associated Intestinal Microbiota
Dan, X., Mushi, Z., Baili, W., Han, L., Enqi, W., Huanhu, Z., & Li, S. (2019) · International Journal of Medical Sciences · doi:10.7150/ijms.29322 · Cited by 166
Differding, M. K., Benjamin‐Neelon, S. E., Hoyo, C., Østbye, T., & Mueller, N. T. (2020) · BMC Microbiology · doi:10.1186/s12866-020-01723-9 · Cited by 160
Self-citationJefferson, A., & Adolphus, K. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00033 · Cited by 149
“(62) demonstrated that in Columbian Frontiers in Nutrition | www.”
BackgroundEcklu-Mensah, G., Choo-Kang, C., Maseng, M. G., Donato, S., Bovet, P., Viswanathan, B., Bedu-Addo, K., Plange‐Rhule, J., Boateng, P. O., Forrester, T., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40874-x · Cited by 156
Short chain fatty acids: the messengers from down below
Mansuy‐Aubert, V., & Ravussin, Y. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1197759 · Cited by 149
Human Milk Oligosaccharides: Their Effects on the Host and Their Potential as Therapeutic Agents
Rousseaux, A., Brosseau, C., Gall, S. L., Piloquet, H., Barbarot, S., & Bodinier, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.680911 · Cited by 147
“However, the effects of too high SCFAs concentration on the host has to be investigated, has one study found that higher SCFA concentrations were associated with obesity and hypertension in the adult (86).”
BackgroundThe role of the gut microbiota in health and cardiovascular diseases
Wang, L., Wang, S., Zhang, Q., He, C., Fu, C., & Wei, Q. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00091-2 · Cited by 140
Serrano, J., Smith, K. R., Crouch, A. L., Sharma, V., Yi, F., Vargova, V., LaMoia, T. E., Dupont, L. M., Serna, V. A., Tang, F., et al. (2021) · Microbiome · doi:10.1186/s40168-020-00976-w · Cited by 137
Verma, A., Bhagchandani, T., Rai, A., Nikita, N., Sardarni, U. K., Bhavesh, N. S., Gulati, S., Malik, R., & Tandon, R. (2024) · ACS Omega · doi:10.1021/acsomega.3c05846 · Cited by 136
Focus on the Gut–Kidney Axis in Health and Disease
Stavropoulou, E., Kantartzi, K. M., Tsigalou, C., Konstantinidis, T. G., Romanidou, G. V., Voidarou, C. C., & Bezirtzoglou, E. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2020.620102 · Cited by 141
“Moreover, higher fecal SCFA levels are associated with hypertension, gut dysbiosis, obesity, and cardiometabolic disease (84), which act to damage the kidney (132, 135, 136).”
BackgroundRecent advances in modulation of cardiovascular diseases by the gut microbiota
Masenga, S. K., Hamooya, B., Hangoma, J., Hayumbu, V., Ertuglu, L. A., Ishimwe, J., Rahman, S., Saleem, M., Laffer, C. L., Elijovich, F., et al. (2022) · Journal of Human Hypertension · doi:10.1038/s41371-022-00698-6 · Cited by 121
The Implication of Short-Chain Fatty Acids in Obesity and Diabetes
Anachad, O., Taouil, A., Taha, W., Bennis, F., & Chegdani, F. (2023) · Microbiology Insights · doi:10.1177/11786361231162720 · Cited by 130
“109,111 Because SCFAs may contribute to the pathophysiology of obesity, they may also have a significant impact on obesity-related illnesses like type 2 diabetes mellitus (T2DM), by influencing body weight control across effects on energy expenditure, energy intake, systemic low-grade inflammation,…”
BackgroundLordan, C., Roche, A. K., Delsing, D. J. M., Nauta, A., Groeneveld, A., MacSharry, J. A., Cotter, P. D., & van Sinderen, D. (2024) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00094-23 · Cited by 130
Microbiota-derived short-chain fatty acids: Implications for cardiovascular and metabolic disease
Lu, Y., Zhang, Y., Zhao, X., Shang, C., Xiang, M., Li, L., & Cui, X. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.900381 · Cited by 125
“A441 community-dwelling adult study found that fecal SCFAs was negatively correlated with the serum lipopolysaccharidebinding protein (LBP) concentrations, a biomarker produced to response to LPS microbial translocation and a marker of gut permeability (79).”
BackgroundChen, L., He, F. J., Dong, Y., Huang, Y., Wang, C., Harshfield, G. A., & Zhu, H. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.14800 · Cited by 123
The Role of Short-Chain Fatty Acids of Gut Microbiota Origin in Hypertension
Wu, Y., Xu, H., Tu, X., & Gao, Z. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.730809 · Cited by 123
“SCFAs not only directly affect hypertension progression but also regulate several hypertension-related syndromes, such as obesity, insulin sensitivity and diabetes (de la Cuesta-Zuluaga et al., 2018; Mandaliya and Seshadri, 2019; Zhi et al., 2019).”
BackgroundNettleton, J. E., Cho, N. A., Klančič, T., Nicolucci, A. C., Shearer, J., Borgland, S. L., Johnston, L., Ramay, H. R., Tuplin, E. W. N., Chleilat, F., et al. (2020) · Gut · doi:10.1136/gutjnl-2018-317505 · Cited by 118
Improving obesity and blood pressure
Tanaka, M. (2019) · Hypertension Research · doi:10.1038/s41440-019-0348-x · Cited by 121
Deng, K., Xu, J., Shen, L., Zhao, H., Gou, W., Xu, F., Fu, Y., Jiang, Z., Shuai, M., Li, B., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36256-y · Cited by 121
Pathophysiology of the Nondipping Blood Pressure Pattern
Huart, J., Persu, A., Lengelé, J., Krzesinski, J.-M., Jouret, F., & Stergiou, G. S. (2023) · Hypertension · doi:10.1161/hypertensionaha.122.19996 · Cited by 113
Hydrogen Sulfide Produced by Gut Bacteria May Induce Parkinson’s Disease
Murros, K. E. (2022) · Cells · doi:10.3390/cells11060978 · Cited by 113
Effects of the microalgae Chlamydomonas on gastrointestinal health
Fields, F. J., Lejzerowicz, F., Schroeder, D., Ngoi, S. M., Tran, M., McDonald, D., Jiang, L., Chang, J. T., Knight, R., & Mayfield, S. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103738 · Cited by 104
Insights on Dietary Polyphenols as Agents against Metabolic Disorders: Obesity as a Target Disease
Aloo, S. O., Ofosu, F. K., Kim, N.-H., Kilonzi, S. M., & Oh, D. (2023) · Antioxidants · doi:10.3390/antiox12020416 · Cited by 107
Mueller, N. T., Zhang, M., Juraschek, S. P., Miller, E. R., & Appel, L. J. (2019) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqz322 · Cited by 106
“More studies are needed to evaluate the associations of circulating SCFAs with cardiometabolic health in comparison with fecal SCFAs, which have been associated with greater obesity (49–51) and worse cardiometabolic health (11).”
BackgroundSelf-citationJones, J. C., Reinke, S. N., Alishum, A., Palmer, D. J., & Christophersen, C. T. (2021) · Scientific Reports · doi:10.1038/s41598-021-93031-z · Cited by 103
The Therapeutic Effect of SCFA-Mediated Regulation of the Intestinal Environment on Obesity
You, H., Tan, Y., Yu, D., Qiu, S., Bai, Y., He, J., Cao, H., Che, Q., Guo, J., & Su, Z. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.886902 · Cited by 105
“Some species of microbes can play specific roles (26, 103).”
BackgroundMaki, K. A., Burke, L., Calik, M. W., Watanabe‐Chailland, M., Sweeney, D., Romick‐Rosendale, L. E., Green, S. J., & Fink, A. M. (2020) · Physiological Genomics · doi:10.1152/physiolgenomics.00039.2020 · Cited by 103
Wang, Z., Liu, J., Li, F., Luo, Y., Ge, P., Zhang, Y., Wen, H., Yang, Q., Ma, S., & Chen, H. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106321 · Cited by 107
Sun, Y., Liu, Y., Ai, C., Song, S., & Chen, X. (2019) · Food & Function · doi:10.1039/c9fo00713j · Cited by 100
A cross-talk between gut microbiome, salt and hypertension
Naqvi, S., Asar, T. O., Kumar, V., Al-Abbasi, F. A., Alhayyani, S., Kamal, M. A., & Anwar, F. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111156 · Cited by 99
Busnelli, M., Manzini, S., & Chiesa, G. (2019) · Nutrients · doi:10.3390/nu12010079 · Cited by 98
Nutritional and health factors affecting the bioavailability of calcium: a narrative review
Wawrzyniak, N., & Suliburska, J. (2020) · Nutrition Reviews · doi:10.1093/nutrit/nuaa138 · Cited by 101
The Implication of the Gut Microbiome in Heart Failure
Lupu, V. V., Răileanu, A. A., Mihai, C. M., Morariu, I. D., Lupu, A., Stârcea, I. M., Frăsinariu, O. E., Mocanu, A., Dragan, F., & Fotea, S. (2023) · Cells · doi:10.3390/cells12081158 · Cited by 98
Nettleton, J. E., Klančič, T., Schick, A., Choo, A. C., Shearer, J., Borgland, S. L., Chleilat, F., Mayengbam, S., & Reimer, R. A. (2019) · Nutrients · doi:10.3390/nu11061248 · Cited by 93
“Studies have found a positive association between fecal SCFA and central adiposity, body mass index, and serum lipids [65,66], and we observed reduced SCFA concentration in prebiotic animals that had improved body composition.”
BackgroundFarràs, M., Martínez-Gili, L., Portune, K. J., Arranz, S., Frost, G. S., Tondo, M., & Blanco‐Vaca, F. (2020) · Nutrients · doi:10.3390/nu12082200 · Cited by 92
Gut Microbial Metabolites and Blood Pressure Regulation: Focus on SCFAs and TMAO
Poll, B. G., Cheema, M. U., & Pluznick, J. L. (2020) · Physiology · doi:10.1152/physiol.00004.2020 · Cited by 88
Münte, E., & Hartmann, P. (2025) · Biomolecules · doi:10.3390/biom15040469 · Cited by 89
Gut microbiota is associated with metabolic health in children with obesity
Alcazar, M., Escribano, J., Ferré, N., Closa-Monasterolo, R., Selma‐Royo, M., Feliu, A., Castillejo, G., Luque, V., Closa-Monasterolo, R., Escribano, J., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.06.007 · Cited by 88
Gut Microbiota Characteristics of People with Obesity by Meta-Analysis of Existing Datasets
Gong, J., Shen, Y., Zhang, H., Cao, M., Guo, M., He, J., Zhang, B., & Xiao, C. (2022) · Nutrients · doi:10.3390/nu14142993 · Cited by 93
Intestinal microbial metabolites in human metabolism and type 2 diabetes
Herrema, H., & Niess, J. H. (2020) · Diabetologia · doi:10.1007/s00125-020-05268-4 · Cited by 86
The Role of Gut Microbiome in Sleep Quality and Health: Dietary Strategies for Microbiota Support
Sejbuk, M., Siebieszuk, A., & Witkowska, A. M. (2024) · Nutrients · doi:10.3390/nu16142259 · Cited by 92
“Interestingly, elevated SCFA in feces is also observed in individuals with obesity-related diseases [54,59,60].”
BackgroundMagzal, F., Even, C., Haimov, I., Agmon, M., Asraf, K., Shochat, T., & Tamir, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-83389-5 · Cited by 86
Shil, A., & Chichger, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105228 · Cited by 89
“Higher SCFA concentrations have been linked with increased gut dysbiosis, gut permeability and are indicators of various metabolic diseases, whilst improved microbial diversity showed opposite correlation with these outcomes [10].”
BackgroundYuan, L., Xie, Z., Gao, T., Li, L., Chen, Y., Xiao, D., Liu, W., Zou, B., Lu, B., Tian, X., et al. (2019) · Food & Function · doi:10.1039/c9fo00213h · Cited by 87
Kaur, H., Golovko, S. A., Golovko, M. Y., Singh, S., Darland, D. C., & Combs, C. K. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200436 · Cited by 82
“For example, changes in plasma as well as fecal SCFA concentrations have been associated with several metabolic disorders [44–46].”
Role of the Gut Microbiome in the Development of Atherosclerotic Cardiovascular Disease
Samarraie, A. A., Pichette, M., & Rousseau, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065420 · Cited by 88
Juárez‐Fernández, M., Román-Sagüillo, S., Porras, D., García‐Mediavilla, M. V., Linares, P., Ballesteros-Pomar, M. D., Urioste-Fondo, A., Álvarez-Cuenllas, B., González‐Gallego, J., Sánchez‐Campos, S., et al. (2021) · Nutrients · doi:10.3390/nu13082519 · Cited by 78
“Therefore, high levels of these metabolites have been related to cardiometabolic and hepatic health [56–58], but also have been associated with gut dysbiosis, gut permeability and excess adiposity [10,59].”
BackgroundDietary fibre and the gut–brain axis: microbiota-dependent and independent mechanisms of action
Torre, D. L., Verbeke, K., & Dalile, B. (2021) · Gut Microbiome · doi:10.1017/gmb.2021.3 · Cited by 84
“Only correlational evidence exists in humans, which indicate that higher SCFA-producing bacteria are associated with lower blood pressure and high faecal SCFA levels (De La Cuesta-Zuluaga et al., 2019; Verhaar et al., 2020).”
Pisanu, S., Palmas, V., Madau, V., Casula, E., Deledda, A., Cusano, R., Uva, P., Vascellari, S., Boi, F., Loviselli, A., et al. (2020) · Nutrients · doi:10.3390/nu12092707 · Cited by 81
Understanding the Effects of Antipsychotics on Appetite Control
Mukherjee, S., Skrede, S., Milbank, E., Andriantsitohaina, R., López, M., & Fernø, J. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.815456 · Cited by 83
Yamamura, R., Nakamura, K., Kitada, N., Aizawa, T., Shimizu, Y., Nakamura, K., Ayabe, T., Kimura, T., & Tamakoshi, A. (2019) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.19-010 · Cited by 82
Omega-3 Fatty Acids and Adipose Tissue: Inflammation and Browning
Kalupahana, N. S., Goonapienuwala, B. L., & Moustaid-Moussa, N. (2020) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-122319-034142 · Cited by 72
Dietary natural products as epigenetic modifiers in aging-associated inflammation and disease
Evans, L. W., Stratton, M. S., & Ferguson, B. S. (2020) · Natural Product Reports · doi:10.1039/c9np00057g · Cited by 73
Magzal, F., Shochat, T., Haimov, I., Tamir, S., Asraf, K., Arieli, M., Even, C., & Agmon, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-05099-w · Cited by 72
Su, L., Zeng, Y., Li, G., Chen, J., & Chen, X. (2022) · Phytotherapy Research · doi:10.1002/ptr.7575 · Cited by 72
Manipulating Gut Microbiota Composition to Enhance the Therapeutic Effect of Cancer Immunotherapy
Yi, M., Jiao, D., Qin, S., Chu, Q., Li, A., & Wu, K. (2019) · Integrative Cancer Therapies · doi:10.1177/1534735419876351 · Cited by 69
A straightforward LC-MS/MS analysis to study serum profile of short and medium chain fatty acids
Dei, M., Paroni, R. C., Saccardo, A., Casagni, E., Arnoldi, S., Gambaro, V., Saresella, M., Clerici, M., Rosa, F. L., Marventano, I., et al. (2020) · Journal of Chromatography B · doi:10.1016/j.jchromb.2020.121982 · Cited by 69
Persistent organic pollutants in foods, their interplay with gut microbiota and resultant toxicity
Goyal, S. P., Badgujar, P. C., Agarwal, T., Bhushan, B., & Mishra, V. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.155084 · Cited by 74
Alderete, T. L., Jones, R. B., Shaffer, J. P., Holzhausen, E. A., Patterson, W. B., Kazemian, E., Chatzi, L., Knight, R. D., Plows, J. F., Berger, P. K., et al. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1961203 · Cited by 71
Short-Chain Fatty Acid Production by Gut Microbiota Predicts Treatment Response in Multiple Myeloma
Rodríguez-García, A., Arroyo, A., García-Vicente, R., Morales, M. L., Gómez-Gordo, R., Justo, P., Cuéllar, C., Sánchez‐Pina, J. M., López‐Muñoz, N., Alonso, R., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-0195 · Cited by 71
Obesity-driven inflammation and cancer risk: A comprehensive review
Lamabadusuriya, D. A., Jayasena, H., Bopitiya, A. K., Silva, A. D. D., & Jayasekera, P. T. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.07.007 · Cited by 76
Virwani, P. D., Qian, G., Hsu, M. S. S., Pijarnvanit, T. K. K. T. S., Cheung, C. N.-M., Chow, Y. H., Lok Kan, T. A. N. G., Tse, Y.-H., Xian, J.-W., Shirley Sau-Wing, L. A. M., et al. (2023) · Hypertension · doi:10.1161/hypertensionaha.122.20752 · Cited by 67
Short-chain fatty acids are potential goalkeepers of atherosclerosis
Feng, Y., & Xu, D. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1271001 · Cited by 69
Gut microbiome diversity and composition is associated with hypertension in women
Louca, P., Nogal, A., Wells, P. M., Asnicar, F., Wolf, J., Steves, C. J., Spector, T. D., Segata, N., Berry, S. E., Valdes, A. M., et al. (2021) · Journal of Hypertension · doi:10.1097/hjh.0000000000002878 · Cited by 70
Qi, R., Sun, J., Qiu, X., Zhang, Y., Wang, J., Wang, Q., Huang, J., Ge, L., & Liu, Z. (2021) · Scientific Reports · doi:10.1038/s41598-021-90881-5 · Cited by 69
Pectin mediates the mechanism of host blood glucose regulation through intestinal flora
Guo, Q., Hou, X., Cui, Q., Li, S., Shen, G., Luo, Q., Wu, H., Chen, H., Liu, Y., Chen, A., et al. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2173719 · Cited by 67
“Although SCFAs are beneficial to the host by improving glucose homeostasis and promoting intestinal health, excess SCFAs are harmful (de la Cuesta-Zuluaga et al. 2018; Kaiko et al. 2016).”
BackgroundRushing, B. R., McRitchie, S., Arbeeva, L. S., Nelson, A. E., Azcárate-Peril, M. A., Li, Y.-Y., Qian, Y., Pathmasiri, W., Sumner, S., & Loeser, R. F. (2021) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2021.10.006 · Cited by 66
Central and peripheral regulations mediated by short-chain fatty acids on energy homeostasis
Luo, P., Lednovich, K., Xu, K., Nnyamah, C., Layden, B. T., & Xu, P. (2022) · Translational research · doi:10.1016/j.trsl.2022.06.003 · Cited by 64
Tilves, C., Yeh, H., Maruthur, N. M., Juraschek, S. P., Miller, E. R., White, K., Appel, L. J., & Mueller, N. T. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.024763 · Cited by 67
Self-citationMueller, N., Differding, M. K., Østbye, T., Hoyo, C., & Benjamin‐Neelon, S. E. (2020) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16633 · Cited by 70
Self-citationEl-Hakim, Y., Mani, K. K., Eldouh, A., Pandey, S., Grimaldo, M. T., Dabney, A. R., Pilla, R., & Sohrabji, F. (2021) · Biology of Sex Differences · doi:10.1186/s13293-020-00352-1 · Cited by 63
Causality of gut microbiome and hypertension: A bidirectional mendelian randomization study
Li, Y., Fu, R., Li, R., Zeng, J., Liu, T., Li, X., & Jiang, W. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1167346 · Cited by 65
Cao, F., Jin, L., Zhang, C., Gao, Y., Qian, Z., Wen, H., Yang, S., Ye, Z., Hong, L., Huang, Y., et al. (2023) · Advanced Materials · doi:10.1002/adma.202304257 · Cited by 66
Integrated omics analysis reveals the alteration of gut microbe–metabolites in obese adults
Li, R., Huang, X., Xiao, L., Su, M., Lai, K. P., & Chen, J. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa165 · Cited by 61
Yuan, X., Chang, C., Chen, X., & Li, K. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-03009-8 · Cited by 61
“Observational studies often include interactions between the gastrointestinal microbiome and various human diseases such as obesity [59], diabetes [60], and irritable bowel syndrome [61].”
BackgroundIntertwined Relationship of Mitochondrial Metabolism, Gut Microbiome and Exercise Potential
Imdad, S., Lim, W., Kim, J., & Kang, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052679 · Cited by 75
“Higher SCFA excretion in feces has been linked with gut dysbiosis, gut permeability, excessive adiposity, and cardiometabolic dysregulations, such as obesity and hypertension [55].”
BackgroundRui, Y., Wan, P., Chen, G., Xie, M., Sun, Y., Zeng, X., & Liu, Z. (2019) · LWT · doi:10.1016/j.lwt.2019.108508 · Cited by 60
Diet-Related Changes of Short-Chain Fatty Acids in Blood and Feces in Obesity and Metabolic Syndrome
Ilyés, T., Silaghi, C. N., & Craciun, A. M. (2022) · Biology · doi:10.3390/biology11111556 · Cited by 66
“The concentration of fSCFA was inversely associated with microbiome diversity [123].”
BackgroundResultInfluentialPulmonary arterial hypertension-associated changes in gut pathology and microbiota
Sharma, R. K., Oliveira, A. C. D. S., Yang, T., Kim, S., Zubcevic, J. A., Aquino, V. P., Lobaton, G. O., Goel, R., Richards, E. M., & Raizada, M. K. (2020) · ERJ Open Research · doi:10.1183/23120541.00253-2019 · Cited by 65
Metadata
- Authors
- De la Cuesta-Zuluaga, J., Mueller, N., Álvarez-Quintero, R., Velásquez-Mejía, E., Sierra, J., Corrales-Agudelo, V., Carmona, J., Abad, J., & Escobar, J.
- Affiliations
- Vidarium–Nutrition, Health and Wellness Research Center, Grupo Empresarial Nutresa, Calle 8 sur #50-67, 050023 Medellin, Colombia
- Johns Hopkins University (US)
- Grupo de Investigación en Sustancias Bioactivas, Sede de Investigación Universitaria (SIU), Universidad de Antioquia, Calle 62 #52-59, 050010 Medellin, Colombia
- Vidarium - Centro de Investigación en Nutrición Salud y Bienestar (CO)
- Dinámica IPS, Especialista en Ayudas Diagnósticas, Calle 27 #45-109, 050021 Medellin, Colombia
- EPS SURA, Calle 49A #63-55, 050034 Medellin, Colombia
- Corresponding author
- Escobar, Juan
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2018-12-27
- Volume
- 11
- Issue
- 1
- Pages
- 51
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC6356834
- OpenAlex
- W2908425894
- Semantic Scholar
- 5eb68bb6bfbbdde0888adeae7373bb6a65842f51
- Cited by
- 533
- References
- 55
- Citations by year
- 2026: 43 · 2025: 61 · 2024: 85 · 2023: 82 · 2022: 81 · 2021: 91 · 2020: 58 · 2019: 31
- FWCI
- 16.00
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Heart, Lung, and Blood Institute (K01HL141589)
- Mid-Atlantic Nutrition Obesity Research Center (P30DK072488)
- Foundation for Gender Specific Medicine (NA)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- short-chain fatty acids, fecal SCFA, gut dysbiosis, microbiome diversity, intestinal permeability, obesity, hypertension, cardiometabolic risk factors, dietary fiber fermentation, acetate, butyrate, propionate
- MeSH terms
- Gastrointestinal Microbiome, Adolescent, Adult, Cardiovascular Diseases, Fatty Acids, Volatile, Feces, Female, Humans, Hypertension, Male, Metabolic Diseases, Middle Aged, Obesity, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.